Post-polio Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition:   Post-polio SyndromeInterventions:   Biological: Flebogamma 5% DIF;   Other: PlaceboSponsors:   Instituto Grifols, S.A.;   Grifols Biologicals Inc.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2014 Category: Research Source Type: clinical trials

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition:   Post-polio SyndromeInterventions:   Biological: Flebogamma 5% DIF;   Other: PlaceboSponsor:   Instituto Grifols, S.A.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2014 Category: Research Source Type: clinical trials

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition:   Post-polio SyndromeInterventions:   Biological: Flebogamma 5% DIF;   Other: PlaceboSponsors:   Instituto Grifols, S.A.;   Grifols Biologicals Inc.Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2014 Category: Research Source Type: clinical trials